Literature DB >> 24162271

Mesenchymal stem cells and granulomas in Crohn's disease and intestinal tuberculosis: the way forward.

Nayak Suprabha1, C Ganesh Pai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24162271     DOI： 10.1007/s10620-013-2909-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

Review 2.  Immunomodulatory properties of mesenchymal stromal cells.

Authors:  Alma J Nauta; Willem E Fibbe
Journal:  Blood       Date:  2007-07-30       Impact factor: 22.113

Review 3.  Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010.

Authors:  Anna Benjamin Pulimood; Deepak Narayan Amarapurkar; Ujjala Ghoshal; Mathew Phillip; Cannanore Ganesh Pai; Duvvur Nageshwar Reddy; Birender Nagi; Balakrishna Siddhartha Ramakrishna
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

4.  Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'?

Authors:  Silvio Danese; Sergio Rutella; Stefania Vetrano
Journal:  Gut       Date:  2012-12-22       Impact factor: 23.059

5.  Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot study.

Authors:  Rupa Banerjee; M Balaji; M Sasikala; S Anuradha; G V Rao; D Nageshwar Reddy
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

6.  Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells.

Authors:  Shilpa Raghuvanshi; Pawan Sharma; Sarman Singh; Luc Van Kaer; Gobardhan Das
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

7.  Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.

Authors:  Rachele Ciccocioppo; Maria Ester Bernardo; Adele Sgarella; Rita Maccario; Maria Antonietta Avanzini; Cristina Ubezio; Antonella Minelli; Costanza Alvisi; Alessandro Vanoli; Fabrizio Calliada; Paolo Dionigi; Cesare Perotti; Franco Locatelli; Gino Roberto Corazza
Journal:  Gut       Date:  2011-01-21       Impact factor: 23.059

8.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.